Le Lézard
Classified in: Health
Subject: PDT

NutriGold® Raises The Bar Again With Omega-3 Fish Oils in Non-GMO Project Verified Next-Generation PlantGelstm


OREM, Utah, Nov. 20, 2017 /PRNewswire/ -- NutriGold, an industry leader in certified organic and Non-GMO Projecttm verified supplements, proudly announces the launch of its Non-GMO Project verified omega-3 fish oils in innovative, next-generation PlantGelstm? a plant-based vegan softgel made from tapioca. PlantGelstmrepresent a cleaner and healthier alternative to soft gels made using carrageenan, bovine, porcine, or fish gelatin.

NutriGold's innovative PlantGels give rise to Non-GMO Project Verified Omega-3 Fish Oil in easy-to-swallow softgels

PlantGelstm help address existing barriers to Non-GMO Project verification for products encapsulated using animal gelatin because of inherent challenges in verifying the non-GMO status of a source animal's feedstock. This launch expresses NutriGold's commitment to the Non-GMO Project in the strongest way possible and reinforces its position as the industry leader in innovative, clean-label products.

When asked about the transition to PlantGelstm, Osman Khan, COO and co-founder of NutriGold, said, "Our success with PlantGelstm is the culmination of previously unsuccessful attempts to replace animal-sourced gelatin in our omega-3 products with a plant-based alternative that is not only safer than carrageenan but also meets our exacting purity and safety standards."

Like all NutriGold® products, Omega-3 Fish Oils are independently verified to meet purity, potency, and freshness standards, so consumers can be confident that what's on the label is actually in the bottle. NutriGold's Omega-3 Fish Oils are:

About NutriGold®
Powered by integrity and guided by our core values of sustainability, quality, accountability, and authentic transparency, NutriGold's mission is to help create a healthier and more sustainable future by making nourishing products, embracing planet-friendly practices, and empowering consumers through education. To learn more, please visit www.Nutrigold.com and join us on social platforms @NutriGoldUSA. NutriGold ? Powered by Integrity®

Contact

Corinna Bellizzi

Tel

+1-866-224-4680

Email

[email protected]  

Website

www.nutrigold.com

 

NutriGold Logo (PRNewsfoto/NutriGold)

SOURCE NutriGold


These press releases may also interest you

at 05:25
PureTech Announces Annual Results for Year Ended December 31, 2023
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
Aquaporin raises DKK 172 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance HealthCare Group expands luxury mental health and addiction services for UHNW individuals
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions and The Pathway join forces to elevate continuing education in restorative dentistry.
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

More news about Health...


News published on and distributed by: